Surgical Treatment of the Patients With Restrictive Phenotype of the Hypertrophic Cardiomyopathy Without LVOT Obstruction
Launched by PETROVSKY NATIONAL RESEARCH CENTRE OF SURGERY · May 15, 2025
Trial Information
Current as of July 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hypertrophic apical cardiomyopathy according to medical records
- • Surgical left ventricular remodeling performed
- Exclusion Criteria:
- • LVOT gradient greater than 30 mmHg
About Petrovsky National Research Centre Of Surgery
The Petrovsky National Research Centre of Surgery is a leading clinical research institution dedicated to advancing surgical techniques and improving patient outcomes through innovative research and development. With a strong emphasis on multidisciplinary collaboration, the Centre integrates cutting-edge technology and evidence-based practices to conduct high-quality clinical trials. Its team of expert surgeons, researchers, and healthcare professionals is committed to exploring new frontiers in surgical science, ensuring that their findings contribute significantly to the global medical community and enhance the standards of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Sergey L Dzemeshkevich, MD, PhD, Prof.
Principal Investigator
Petrovsky National Research Centre of Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported